Selective Induction of Apoptosis by Histone Deacetylase Inhibitor SAHA in Cutaneous T-Cell Lymphoma Cells: Relevance to Mechanism of Therapeutic Action-Reference-Cited by-同舟云学术

Selective Induction of Apoptosis by Histone Deacetylase Inhibitor SAHA in Cutaneous T-Cell Lymphoma Cells: Relevance to Mechanism of Therapeutic Action

Published:2005-11 Issue:5 Volume:125 Page:1045-1052
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Zhang Chunlei,Richon Victoria,Ni Xiao,Talpur Rakhshandra,Duvic Madeleine

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference47 articles.

1. Phototherapy for cutaneous T-cell lymphoma;Baron;Dermatol Ther,2003

2. The relevance of the CD4+CD26- subset in the identification of circulating Sezary cells;Bernengo;Br J Dermatol,2001

3. Efficacy of ultraviolet A1 phototherapy on the expression of bcl-2 in atopic dermatitis and cutaneous T-cell lymphoma in vivo: A comparison study;Breuckmann;Photodermatol Photoimmunol Photomed,2002

4. STAT proteins: From normal control of cellular events to tumorigenesis;Calo;J Cell Physiol,2003

5. Histone deacetylases (HDACs): Characterization of the classical HDAC family;de Ruijter;Biochem J,2003

Cited by 219 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reversion from basal histone H4 hypoacetylation at the replication fork increases DNA damage in FANCA deficient cells;PLOS ONE;2024-05-31

2. Mechanistic Sequence of Histone Deacetylase Inhibitors and Radiation Treatment: An Overview;Pharmaceuticals;2024-05-08

3. Glioma Stem Cells Are Sensitized to BCL-2 Family Inhibition by Compromising Histone Deacetylases;International Journal of Molecular Sciences;2023-09-05

4. Tissue‐Engineered Disease Modeling of Lymphangioleiomyomatosis Exposes a Therapeutic Vulnerability to HDAC Inhibition;Advanced Science;2023-07-03

5. Clinical Experience with Epigenetic Drugs in Lymphoid Malignancies;Precision Cancer Therapies, Volume 1 ‐ Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies;2023-03-15